SCHEMBL19142137

SCHEMBL19142137

C=CSc1nc(Cl)nc(N2CCOCC2)c1CC

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 1/20 0.45
SMN1; SMN2 Q16637 4/20 0.38
KMT2A Q03164 6/20 0.35
MEN1 O00255 3/20 0.35
TSHR P16473 2/20 0.35
HSD17B10 Q99714 2/20 0.35
ALDH1A1 P00352 6/20 0.35
LMNA P02545 5/20 0.35
HPGD P15428 1/20 0.35
MAPT P10636 5/20 0.34
GAA P10253 1/20 0.34
MAPK1 P28482 1/20 0.34
KDM4E B2RXH2 3/20 0.33
HTT P42858 2/20 0.33
POLB P06746 3/20 0.33
NPSR1 Q6W5P4 1/20 0.32
PDE10A Q9Y233 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5458262 0.71 NUDT1 (0.50) NUDT1SMN1; SMN2KMT2AMEN1TSHR
SCHEMBL13828994 0.68 NUDT1 (0.46) NUDT1SMN1; SMN2KMT2AMEN1TSHR
SCHEMBL19155514 0.67 SMN1; SMN2 (0.38) NUDT1SMN1; SMN2TSHRALDH1A1LMNA
SCHEMBL25229551 0.66 CYP3A4 (0.45) SMN1; SMN2TSHRHSD17B10ALDH1A1HPGD
SCHEMBL7930954 0.65 SMN1; SMN2 (0.49) SMN1; SMN2HSD17B10ALDH1A1LMNAMAPT
SCHEMBL25737360 0.65 NUDT1 (0.38) NUDT1SMN1; SMN2KMT2AMEN1TSHR
SCHEMBL24710969 0.65 NUDT1 (0.43) NUDT1SMN1; SMN2KMT2AMEN1TSHR
SCHEMBL4973147 0.64 SMN1; SMN2 (0.48) SMN1; SMN2KMT2AHSD17B10ALDH1A1LMNA
SCHEMBL2815267 0.64 MAPK1 (0.51) NUDT1SMN1; SMN2KMT2AMEN1TSHR
SCHEMBL13828583 0.64 SMN1; SMN2 (0.48) NUDT1SMN1; SMN2KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046799-B1 PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GENENTECH INC (US) 2017-07-19 EP disclosed